Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2005 3
2006 1
2007 1
2009 1
2010 1
2011 5
2012 1
2013 3
2014 3
2015 7
2016 6
2017 9
2018 9
2019 6
2020 5
2021 4
2022 3
2023 1
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

62 results

Results by year

Filters applied: . Clear all
Page 1
Vaccine options for influenza: thinking small.
Schepens B, De Vlieger D, Saelens X. Schepens B, et al. Curr Opin Immunol. 2018 Aug;53:22-29. doi: 10.1016/j.coi.2018.03.024. Epub 2018 Apr 7. Curr Opin Immunol. 2018. PMID: 29631195 Review.
Clinical Potential of Prefusion RSV F-specific Antibodies.
Rossey I, McLellan JS, Saelens X, Schepens B. Rossey I, et al. Among authors: schepens b. Trends Microbiol. 2018 Mar;26(3):209-219. doi: 10.1016/j.tim.2017.09.009. Epub 2017 Oct 17. Trends Microbiol. 2018. PMID: 29054341 Review.
Single-domain antibodies make a difference.
Saelens X, Schepens B. Saelens X, et al. Among authors: schepens b. Science. 2021 Feb 12;371(6530):681-682. doi: 10.1126/science.abg2294. Science. 2021. PMID: 33574203 No abstract available.
Regulation of kynurenine biosynthesis during influenza virus infection.
Gaelings L, Söderholm S, Bugai A, Fu Y, Nandania J, Schepens B, Lorey MB, Tynell J, Vande Ginste L, Le Goffic R, Miller MS, Kuisma M, Marjomäki V, De Brabander J, Matikainen S, Nyman TA, Bamford DH, Saelens X, Julkunen I, Paavilainen H, Hukkanen V, Velagapudi V, Kainov DE. Gaelings L, et al. Among authors: schepens b. FEBS J. 2017 Jan;284(2):222-236. doi: 10.1111/febs.13966. Epub 2016 Dec 14. FEBS J. 2017. PMID: 27860276 Free article.
Nanobodies®: new ammunition to battle viruses.
Vanlandschoot P, Stortelers C, Beirnaert E, Ibañez LI, Schepens B, Depla E, Saelens X. Vanlandschoot P, et al. Among authors: schepens b. Antiviral Res. 2011 Dec;92(3):389-407. doi: 10.1016/j.antiviral.2011.09.002. Epub 2011 Sep 10. Antiviral Res. 2011. PMID: 21939690 Review.
M2e-based universal influenza A vaccine.
Fiers W, De Filette M, El Bakkouri K, Schepens B, Roose K, Schotsaert M, Birkett A, Saelens X. Fiers W, et al. Among authors: schepens b. Vaccine. 2009 Oct 23;27(45):6280-3. doi: 10.1016/j.vaccine.2009.07.007. Vaccine. 2009. PMID: 19840661 Review.
GlycoVHH: optimal sites for introducing N-glycans on the camelid VHH antibody scaffold and use for macrophage delivery.
van Schie L, Van Breedam W, Roels C, Schepens B, Frank M, Mehdipour AR, Laukens B, Nerinckx W, Santens F, Devos S, Rossey I, Thooft K, Vanmarcke S, Van Hecke A, Saelens X, Callewaert N. van Schie L, et al. Among authors: schepens b. MAbs. 2023 Jan-Dec;15(1):2210709. doi: 10.1080/19420862.2023.2210709. MAbs. 2023. PMID: 37211816 Free PMC article.
62 results